Hospital-acquired, ≥ 4 days hospitalization
- Majority of cases occur in second week of hospitalization.
- Risk factors:
mechanical ventilation
facial/cranial fractures
nasal packing
nasogastric/nasoendotracheal tubes
otitis media post head trauma
corticosteroid therapy
prior antibiotic use.
- Black, necrotic tissue or discharge in patients with poorly controlled diabetes/ketoacidosis, or with significant immunosuppression, may indicate mucormycosis. Recommend urgent ENT/ID consult.
- Recommend:
- ENT consult
- Remove nasogastric/nasoendotracheal tube
- Semi-recumbent (30-45°) positioning
-
Sinus aspiration for C&S:
tailor antibiotics to C&S results.
- If no response to therapy in 7 days, insertion of a drainage catheter should be considered.
Usual Pathogens
Enterobacterales
P. aeruginosa
Acinetobacter spp
S. aureus/MRSA
Yeast
Empiric Therapy | Dose | Duration |
---|---|---|
Clindamycin IV/PO | 600mg IV q8h/ 300mg PO qid |
7-10 days |
+ | ||
Ciprofloxacin IV/PO | 400mg IV q12h/ 750mg PO bid |
Severe
Empiric Therapy | Dose | Duration |
---|---|---|
Piperacillin-tazobactam | 4.5g IV q6h | 7-10 days |
or
Facial fractures, head trauma, CNS infection/meningitis suspected
Empiric Therapy | Dose | Duration |
---|---|---|
Meropenem | 2g IV q8h | 7-10 days |